NLA Recommendations & Statements
The NLA released an official scientific statement on Lipoprotein(a) [Lp(a)] designed as a comprehensive source of guidance for medical professionals making decisions to improve the health and well-being of children and adults at risk of premature cardiovascular disease.
Publish Date:
April 29, 2019 - 9:00am
Last Updated: May, 2020
The NLA has released a statement paper that provides updated guidance to clinicians to help identify patient groups in whom treatment with PCSK9 monoclonal antibodies (mAbs) provides a reasonable value.
Publish Date:
May 16, 2019 - 3:15pm
Last Updated: Oct, 2019
/sites/default/files/files/2018%20Cholesterol%20Treatment%20Guideline%20%20Presentation%20Slides_NLA.pptxThis document was approved by the American College of Cardiology Clinical Policy Approval Committee, the American Heart Association Science Advisory and Coordinating Committee, American Association of Cardiovascular and Pulmonary Rehabilitation, American Academy of Physician Assistants, Association of Black Cardiologists, American College of Preventive Medicine, American Diabetes Association, American Geriatrics Society, American Pharmacists Association, American Society for Preventive Cardiology, National Lipid Association, and Preventive Cardiovascular Nurses Association in October 2018, and the American Heart Association Executive Committee in October 2018.
Publish Date:
June 8, 2019 - 4:15pm
Last Updated: Oct, 2019
https://www.lipid.org/nla/national-lipid-association-releases-draft-part-two-its-recommendations-patient-centered The NLA Recommendations for Patient-Centered Management of Dyslipidemia, published in the Journal of Clinical Lipidology, re-affirm the importance of cholesterol goals for the prevention of heart attack and stroke. The recommendations should serve as guidance to clinicians for treating patients with dyslipidemia.
Publish Date:
May 17, 2017 - 2:00pm
Last Updated: Dec, 2018
On June 3, 2015, the anticipated final results of the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) was published online in the New England Journal of Medicine (NEJM 2015;372:2387-97).
Publish Date:
June 5, 2015 - 12:00pm
Last Updated: May, 2017